Life insurer embraces diabetes tech

Morning eHealth

Why kidney care depends on health data — Warner dings HHS on privacy

Important Diabetes Tech Advances in Early 2015

Insulin Nation

While you might be going through the same day-in, day-out process to keep blood sugar levels in check, there’s a diabetes technology race afoot. Diabetes tech companies are trying to outdo each other with the latest pump, continuous glucose monitor (CGM), or app to help people with diabetes regulate blood glucose levels. We’ve barely begun 2015, but early returns suggest it’s going to be a banner year for diabetes technology.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Walmart Sells AI-Backed Diabetes Tech Which Makes Blood Sugar Management Suggestions

Healthcare IT Today

If you’re not a diabetic or have never lived with a diabetic loved one, it’s hard to imagine how cumbersome it can be to manage the condition. AI/Machine Learning Analytics/Big Data Clinical Health IT Company Healthcare IT Telemedicine and Remote Monitoring Blood Glucose Meter Blood Glucose Monitoring Chronic Disease Management Diabetes Coaching Diabetes Management Diabetes Management App Digital Therapeutics One Drop Predictive Analytics Smart Glucose Meter Walmart

FDA Support for AID Systems Grows with Backing of New Questionnaires

Insulin Nation

Insulin Dosing Systems: Perceptions, Ideas, Reflections, and Expectations (INSPIRE) questionnaires were developed to help quantify the psychosocial impacts of automated insulin dosing systems on people living with type 1 diabetes and their caregivers. The inclusion of such a tool in the MDDT by the FDA falls in line with a growing trend within the diabetes tech industry to focus on devices that aim to improve more than just blood sugar control.

People with Type 1 Spend More on Supplies Than on Insulin

Insulin Nation

But a new financial study looking at the broader costs of type 1 diabetes calls into question how effective such measures will truly be in reducing the financial burden of living with this disease. The research from Michigan Medicine, which was published in JAMA last month, looked at the diabetes-related out-of-pocket costs of over 65,000 American type 1 patients, ages 1 to 64, who were enrolled in private insurance. The Importance of Affordable Diabetes Supplies.

United Healthcare Reverses Course to Cover Tandem Pumps

Insulin Nation

Prior to this, United Healthcare had an exclusive coverage contract with Medtronic that limited consumer choice to just one brand of insulin pump, a move that was highly criticized within the diabetes community. Medtronic, one of three main insulin pump manufacturers, would secure a huge chunk of the diabetes market because only their pumps would be available to UHC customers. There is no one-size-fits-all approach to treating diabetes.

Hypoglycemia Unawareness: Why It Occurs and What to Do About It

Insulin Nation

For a newly diagnosed type 1 diabetic, there is nothing scarier than having your blood sugar bottom out. While many long-term diabetics have some idea of what hyperglycemia unawareness is, most don’t have a full grasp of why this condition appears or how you can work to avoid or even reverse it. Unfortunately, the normal channels for automatically increasing blood sugar levels don’t work well in insulin-dependent diabetics.

Tandem’s Basal-IQ Gets FDA Interoperable Designation

Insulin Nation

Tandem’s Basal-IQ technology received the FDA’s interoperable automated glycemic controller designation (iAGC) which allows this tech to be paired with different pumps and CGM systems to create an automated insulin dosing (AID) system. This is the second piece of tech from Tandem to receive such designation. Right now, this tech is available to be used with the Tandem t:slim X2 insulin pump and the Dexcom G6 CGM. This type of tech is the basis for all AID systems.

Adults with Type 1 Diabetes Need More Support To Achieve Goals

Insulin Nation

For years, qualitative studies looking into the inherent challenges of achieving diabetes management goals have focused on children and adolescents. Until recently, the group that makes up the largest percentage of those living with type 1 diabetes — adults — has been largely ignored. Why is it that the cohort of diabetics once thought to be the least at risk for suffering from poor control are doing just that? .

A 3-Time Artificial Pancreas Test Subject Speaks

Insulin Nation

Kelly Close, a noted diabetes advocate and author, used to be last in line to embrace new diabetes technology. Her conversion from diabetes tech skeptic to believer was quick, especially as she immediately began to feel better on pump therapy. Now, Close holds the distinction of being one of the few people with diabetes who has participated in three artificial pancreas trials.

Are Exclusive Insurance Contracts Consumer Abuse?

Insulin Nation

A cabin in the middle of nowhere is the last place any diabetic wants to suffer a hypoglycemic emergency. He was well in control of his diabetes and was an old pro at managing the condition on camping trips, during travel, and any other environment you could throw at him. The veteran diabetic had managed to stave off a serious emergency and live to see another day. . Diabetes tech advances in waves, with huge innovations hitting the market at least every two years.

FDA Approves Animas OneTouch Vibe Plus

Insulin Nation

If the past year is any indication, diabetes tech geeks might have to work hard in 2017 to keep up with the latest models of pumps and CGMs on the marketplace. As Diabetes Mine reported at the time of the G5 approval, the swiftness of FDA approval caught even Dexcom execs off-guard. Have Type 2 diabetes or know someone who does?

Newly Diagnosed: 10 Diabetes Truths Veteran T1Ds Want You to Know

Insulin Nation

There is so much to learn when you are first diagnosed with type 1 diabetes. It is this phenomenon — this inability to see beyond everything you need to do just to get through today — that makes it so hard to look at the big picture of living with diabetes. If you are lucky enough to have a strong community of other T1Ds around you, you may even have the opportunity to learn some of these “truths” about the condition long before you have become a veteran diabetic yourself.

How did the 670G and the iLet Perform in Trials?

Insulin Nation

The iLet trial can serve as a reminder to the diabetes tech community that while the 670G may be an important introduction to the era of artificial pancreas technology, it will not be the final word. This trial involved 124 people with Type 1 diabetes, ages 14 to 75. The trial involved 39 adults with Type 1 diabetes over an 11-day period in real-world settings. Have Type 2 diabetes or know someone who does?

I was Diagnosed with Type 1 at 28 Years Old

Insulin Nation

I was diagnosed with Type 1 diabetes on September 26, 2015 at 28 years old. My father had been diagnosed with Type 2 diabetes in July of 2015, so there was a history of diabetes in my immediate family. It turns out she saved my life, because that is where I was diagnosed with Type 1 diabetes. This came as a major surprise because I have been pretty healthy my entire life.

Closed-Loop System Shows Promise for Improving Diabetes Outcomes

Insulin Nation

Unlike other recent studies, this project was more substantial in that it followed participants for a full six months and used newer tech with the power to correct blood sugar levels beyond basal rate adjustment. While their findings should bring hope to the diabetic community as a whole, it is important to dig deeper into the limitations of this new technology. This trial enrolled 168 Type 1 diabetic patients between the ages of 14 and 71.

Confessions of a Diabetes Hacker

Insulin Nation

There is a quiet hacking revolution taking place in the Type 1 diabetes community. While this kind of customized surveillance can be done with current diabetes technology, it has yet to be approved by the FDA. At that time, I knew nothing about diabetes. Some are working in groups, others are working alone, but all share the same goal of making lives for people with diabetes easier, better, and (although they are taking personal risks) safer.

Confessions of a Diabetes Hacker

Insulin Nation

There is a quiet hacking revolution taking place in the Type 1 diabetes community. While this kind of customized surveillance can be done with current diabetes technology, it has yet to be approved by the FDA. At that time, I knew nothing about diabetes. Some are working in groups, others are working alone, but all share the same goal of making lives for people with diabetes easier, better, and (although they are taking personal risks) safer.

The T1 Tech Roundup

Insulin Nation

Insulin Nation strives to keep you up to date on the latest news on diabetes gear. Telcare has unveiled a prototype of something it’s billing as a “Total Diabetes Management” solution, but it’s a bit unclear what it is. Asante, the makers of the Snap pump, have announced they are moving ahead with a venture to make their diabetes data more accessible. Next Up, a Diabetes Breath Mint? Here’s what we’ve found recently that’s noteworthy: The Quest for Less Ouch.

Crowdsourced T1 R&D Fundraising

Insulin Nation

We’ve gotten used to crowdsourcing to fund everything from documentaries to startup clothing lines, but what about advances in diabetes care? Two new fundraising campaigns are crowdsourcing to raise money to foster innovative ways to treat Type 1 diabetes. While diabetes tech companies have raised funds through crowdsourcing campaigns before, this might be the first time that a company is targeting a fundraising campaign to deal specifically with regulatory costs.

How the Trump Immigration Ban Might Affect Diabetes Research

Insulin Nation

Earlier, we reported on how the Trump administration’s executive order on immigration barred Dr. Samira Asgari from joining a research lab that does diabetes research. In addition, EndGadget is reporting that 97 tech firms, including Google, Microsoft, and Apple, have filed an amicus brief in support of lawsuits against the executive order, saying that the brief “inflicts significant harm on American business, innovation and growth.”. Have Type 2 diabetes or know someone who does?